Adial Pharmaceuticals Inc.
ADIL | NASDAQ
$4.40
-$0.46 (-9.47%)
At close: Sep 21, 2026, 4:00 PM ET
$4.48
+$0.08 (+1.82%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.46 | -1.42 | -0.34 | -0.46 | -2.58 | -1.95 |
PEG Ratio | 0.01 | 0.02 | 0.01 | 0.01 | -0.13 | 42.52 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.70 | 4.62 | 0.65 | 1.78 | 14.31 | 5.32 |
P/FCF Ratio | -0.57 | -2.71 | n/a | -0.52 | -4.18 | -2.78 |
P/OCF Ratio | -0.57 | -2.71 | -0.39 | -0.52 | -4.20 | -2.78 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | 0.06 | 0.07 | n/a |
Quick Ratio | 4.42 | 4.16 | 4.90 | 2.67 | 2.37 | 3.41 |
Current Ratio | 4.42 | 4.16 | 4.90 | 2.67 | 2.37 | 3.41 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -151.18% | -324.41% | -171.47% | -388.57% | -553.72% | -272.46% |
Return on Assets | -117.34% | -261.65% | -147.81% | -222.08% | -254.44% | -197.77% |
Return on Invested Capital | -144.40% | -203.65% | -168.66% | -271.57% | -386.93% | -273.34% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ADIL